Lana Giles (nee Poon) is a seasoned professional in pharmacovigilance and process improvement with extensive experience spanning various reputable companies. Currently serving as a PV Consultant at Drive Phase PV since February 2021, Lana has previously held prominent roles including PV Agreements Project Lead and Consultant for Pharmacovigilance Transformation at Elanco, where responsibilities included ensuring regulatory compliance and data availability for Benefit:Risk evaluation. Lana's expertise also encompasses roles at PHARMExcel, Cmed Clinical Services, Quanticate, and major pharmaceutical companies such as Sanofi, GSK, and Daiichi Sankyo. Educational qualifications include an MSc in Management Science and a BSc (Hons) in Microbiology with Medical Biosciences from the University of Kent.